Association between a Suppressive Combined Antiretroviral Therapy Containing Maraviroc and the Hepatitis B Virus Vaccine Response

The response to the HBV vaccine in HIV-infected patients is deficient. Our aim was to analyze whether a suppressive combined antiretroviral treatment (cART) containing maraviroc (MVC-cART) was associated with a better response to HBV vaccine. Fifty-seven patients on suppressor cART were administered...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Herrero-Fernández, Inés, Pacheco, Yolanda M., Genebat, Miguel, Rodriguez-Méndez, María del Mar, Lozano, María del Carmen, Polaino, María José, Rosado-Sánchez, Isaac, Tarancón-Diez, Laura, Muñoz-Fernández, María Ángeles, Ruiz-Mateos, Ezequiel, Leal, Manuel
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2017
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740301/
https://ncbi.nlm.nih.gov/pubmed/29084751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02050-17
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires